J Martin Carroll Esperion Therapeutics, Inc. (ESPR) insider trading activity

ESPR Quotes by TradingView

J Martin Carroll is Director of Esperion Therapeutics, Inc.. Currently has a direct ownership of 64,650 shares of ESPR, which is worth approximately $147,402. The most recent transaction as insider was on May 23, 2024, when has been sold 23,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 64.7K
0% 3M change
55.22% 12M change
Total Value Held $147,402

J MARTIN CARROLL Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2024
BUY
Grant, award, or other acquisition
-
23,000 Added 26.24%
64,650 Common Stock
Jun 15 2023
BUY
Grant, award, or other acquisition
-
5,150 Added 11.0%
41,650 Common Stock
May 11 2023
BUY
Open market or private purchase
$36,252 $1.57 p/Share
23,091 Added 38.75%
36,500 Common Stock
May 10 2023
BUY
Open market or private purchase
$12,529 $1.49 p/Share
8,409 Added 38.54%
13,409 Common Stock
Jun 02 2022
BUY
Open market or private purchase
$28,200 $5.64 p/Share
5,000 Added 50.0%
5,000 Common Stock

Also insider at

CTLT
Catalent, Inc. Healthcare
MNKPF
Mallinckrodt plc Healthcare
Director
TXMD
TherapeuticsMD, Inc. Healthcare
Director
JMC

J Martin Carroll

Director
Somerset, NJ

Track Institutional and Insider Activities on ESPR

Follow Esperion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

News

Receive news related to Esperion Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ESPR